Upgrade to SI Premium - Free Trial

BofA Securities Downgrades Biohaven Pharma (BHVN) to Underperform

June 29, 2026 6:10 AM
(Updated - June 29, 2026 6:13 AM EDT)

BofA Securities analyst Jason Gerberry downgraded Biohaven Pharma (NYSE: BHVN) from ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst PT Change Downgrades